Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 4.906\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] O=c1c2c3c(sc2nc2n1CCCC2)CCCCC3
[b] COC(=O)c1nc(NC(=O)c2ccccc2)n[nH]1
[c] CCC(C)(C)NC(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
[d] C[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCCC[C@@H](C(N)=O)NC1=O
Answer: c. CCC(C)(C)NC(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)NC(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
CCC(C)(C)NC(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
1-[[1-(cyclopropanecarbonyl)-2-methyl-2,3-dihydroindol-5-yl]sulfonyl]-N-(2-methylbutan-2-yl)piperidine-3-carboxamide